Cargando…
Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
INTRODUCTIONS: Ovarian cancer is a stubborn malignancy of gynecological system with a high mortality rate. Docetaxel (DTX), the second-generation of anti-tumor drug Taxane, has shown superior efficacy over classic paclitaxel (PTX) in certain cancers. However, its clinical application is hindered by...
Autores principales: | Hu, Yuzhu, Ran, Mengni, Wang, Bilan, Lin, Yunzhu, Cheng, Yongzhong, Zheng, Songping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721301/ https://www.ncbi.nlm.nih.gov/pubmed/33299312 http://dx.doi.org/10.2147/IJN.S274083 |
Ejemplares similares
-
Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo
por: Zheng, Songping, et al.
Publicado: (2017) -
Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin
por: Ye, Xi, et al.
Publicado: (2022) -
Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy
por: Hu, Yuzhu, et al.
Publicado: (2020) -
New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles
por: Hekmat, Atefeh, et al.
Publicado: (2016) -
The influence of bile salt on the chemotherapeutic response of docetaxel-loaded thermosensitive nanomicelles
por: Kim, Dong Wuk, et al.
Publicado: (2014)